Wellgistics Health, Inc. - SIC # 7352 - MEDICAL EQUIPMENT RENTAL AND LEASING

Ticker Exchange SIC # Website Latest Ticker
WGRX Nasdaq 7352 www.wellgisticshealth.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Wellgistics Health, Inc.

Wellgistics Health Announces Reverse Stock Split - May 20th, 2026 4:00 pm
Wellgistics Health, Datavault AI Agree to Form DelivMeds AI - May 20th, 2026 8:27 am
Wellgistics Health Reports First Quarter 2026 Financials and Provides Business Update - May 19th, 2026 2:10 pm
Wellgistics Health to Announce First Quarter 2026 Financials on Tuesday May 19, 2026 - May 15th, 2026 2:01 pm
Wellgistics Health Accelerates Digital Health Expansion of its Newly Announced RPM, RTM and CCM Pilot with Planned Acquisition of WellCare Today and its Proprietary Samsung Galaxy Watch Care Monitoring Program - May 14th, 2026 1:05 pm
Wellgistics Health Announces Pilot MSO Collaboration with Kare PharmTech Targeting $14 Billion U.S. Market for CCM and RPM Services - May 13th, 2026 7:05 am
Wellgistics Health and Kare PharmTech Execute Joint Venture Expanding Access to 200,000+ Patient Lives - Apr 14th, 2026 5:05 am
Wellgistics Health, Inc. (WGRX) Explores $105M Acquisition of Neuritek to Expand Healthcare Platform - Apr 2nd, 2026 6:08 pm
Thunder Rock Capital Serves as Exclusive M&A Advisor to Neuritek Therapeutics, Inc. on $105,000,000 Proposed Acquisition by Wellgistics Health, Inc. - Mar 25th, 2026 7:15 am
Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders - Mar 23rd, 2026 7:05 am
Wellgistics Management Converts $2 Million in Deferred Compensation into Equity at $0.20 per Share - Mar 19th, 2026 6:05 am
Wellgistics President Releases Letter to Shareholder on Emerging Patient Care-Centric Strategic Direction - Mar 13th, 2026 7:00 am
BC-Most Active Stocks - Mar 12th, 2026 8:30 am
Wellgistics Strengthens PharmacyChain(TM) with Insurance Eligibility & Benefits Verification Capabilities - Mar 11th, 2026 6:30 am
Wellgistics Targets $70B Market Breakthrough Addressing Ozempic / GLP-1 Muscle Loss with Forzet(TM) - Mar 9th, 2026 5:40 am
Wellgistics Health Selects Top Five Blockchain Platforms to Initiate Patent Protected PharmacyChain(TM) Smart Contracts-enabled Pharmaceutical Drug Tracking System to Support Industry-wide Serialization Mandate - Mar 5th, 2026 5:40 am
Datavault AI (DVLT), Wellgistics Health Expand Partnership to Launch Blockchain-Powered HaaS Model - Feb 25th, 2026 3:45 am
DataVault AI and Wellgistics Health Announce Plans to Expand Partnership to Include Healthcare Delivery Intellectual Property for Healthcare as a Service (HaaS) Blockchain-enabled Smart Contracts - Feb 23rd, 2026 6:30 am
Wellgistics Health to Add Telehealth & Mental Health AI Capabilities via Tollo Health Partnership Expansion - Feb 11th, 2026 5:00 am
NFL Alumni Health Partners with Wellgistics Health to Deploy Technology to Improve Health Outcomes for Former NFL Players and Rural Communities - Feb 9th, 2026 6:30 am